Exendin-4 decreases amphetamine-induced locomotor activity

被引:76
作者
Erreger, Kevin [1 ,3 ]
Davis, Adeola R. [1 ,3 ]
Poe, Amanda M. [1 ,3 ]
Greig, Nigel H. [4 ]
Stanwood, Gregg D. [2 ,3 ]
Galli, Aurelio [1 ,3 ]
机构
[1] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37232 USA
[4] NIA, Neurosci Lab, Baltimore, MD 21224 USA
关键词
Amphetamine; Psychostimulant; Glucagon-like peptide-1; Exenatide; Dopamine; GLUCAGON-LIKE PEPTIDE-1; REDUCES FOOD-INTAKE; NUCLEUS-ACCUMBENS; BODY-WEIGHT; INSULIN-RESISTANCE; RECEPTOR AGONISTS; PROMOTES SATIETY; ENERGY-INTAKE; GLP-1; BRAIN;
D O I
10.1016/j.physbeh.2012.03.014
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Glucagon-like peptide-1 (GLP-1) is released in response to nutrient ingestion and is a regulator of energy metabolism and consummatory behaviors through both peripheral and central mechanisms. The GLP-1 receptor (GLP-1R) is widely distributed in the central nervous system, however little is known about how GLP-1Rs regulate ambulatory behavior. The abused psychostimulant amphetamine (AMPH) promotes behavioral locomotor activity primarily by inducing the release of the neurotransmitter dopamine. Here, we identify the GLP-1R agonist exendin-4 (Ex-4) as a modulator of behavioral activation by AMPH. We report that in rats a single acute administration of Ex-4 decreases both basal locomotor activity as well as AMPH-induced locomotor activity. Ex-4 did not induce behavioral responses reflecting anxiety or aversion. Our findings implicate GLP-1R signaling as a novel modulator of psychostimulant-induced behavior and therefore a potential therapeutic target for psychostimulant abuse. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:574 / 578
页数:5
相关论文
共 67 条
[1]   GLP-1 Neurons in the Nucleus of the Solitary Tract Project Directly to the Ventral Tegmental Area and Nucleus Accumbens to Control for Food Intake [J].
Alhadeff, Amber L. ;
Rupprecht, Laura E. ;
Hayes, Matthew R. .
ENDOCRINOLOGY, 2012, 153 (02) :647-658
[2]  
Alvarez E, 1996, J NEUROCHEM, V66, P920
[3]   Biology of incretins: GLP-1 and GIP [J].
Baggio, Laurie L. ;
Drucker, Daniel J. .
GASTROENTEROLOGY, 2007, 132 (06) :2131-2157
[4]   GLP-1 and energy balance: an integrated model of short-term and long-term control [J].
Barrera, Jason G. ;
Sandoval, Darleen A. ;
D'Alessio, David A. ;
Seeley, Randy J. .
NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (09) :507-516
[5]   Orexin A in the VTA is critical for the induction of synaptic plasticity and Behavioral Sensitization to cocaine [J].
Borgland, SL ;
Taha, SA ;
Sarti, F ;
Fields, HL ;
Bonci, A .
NEURON, 2006, 49 (04) :589-601
[6]   Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists [J].
Chartoff, EH ;
Heusner, CL ;
Palmiter, RD .
NEUROPSYCHOPHARMACOLOGY, 2005, 30 (07) :1324-1333
[7]   Ghrelin: a link between energy homeostasis and drug abuse? [J].
Cummings, David E. ;
Naleid, Amy M. ;
Lattemann, Dianne P. Figlewicz .
ADDICTION BIOLOGY, 2007, 12 (01) :1-5
[8]   Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats [J].
de Fonseca, FR ;
Navarro, M ;
Alvarez, E ;
Roncero, I ;
Chowen, JA ;
Maestre, O ;
Gómez, R ;
Muñoz, RM ;
Eng, J ;
Blázquez, E .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (06) :709-717
[9]   The Gut Hormones PYY3-36 and GLP-17-36 amide Reduce Food Intake and Modulate Brain Activity in Appetite Centers in Humans [J].
De Silva, Akila ;
Salem, Victoria ;
Long, Christopher J. ;
Makwana, Aidan ;
Newbould, Rexford D. ;
Rabiner, Eugenii A. ;
Ghatei, Mohammad A. ;
Bloom, Stephen R. ;
Matthews, Paul M. ;
Beaver, John D. ;
Dhillo, Waljit S. .
CELL METABOLISM, 2011, 14 (05) :700-706
[10]   Glucagon-Like Peptide 1 Receptors in Nucleus Accumbens Affect Food Intake [J].
Dossat, Amanda M. ;
Lilly, Nicole ;
Kay, Kristen ;
Williams, Diana L. .
JOURNAL OF NEUROSCIENCE, 2011, 31 (41) :14453-14457